← All Sponsors
SPONSOR

Longboard Pharmaceuticals

Total Trials
2
Recruiting
2
Phases
Phase 3
Conditions studied: Developmental and Epileptic EncephalopathyDravet Syndrome
NCT06719141 Phase 3
Recruiting

A Study to Investigate LP352 in Children and Adults With Developmental and Epileptic Encephalopathies (DEE)

Developmental and Epileptic Encephalopathy
United States, Australia, Belgium View Trial →
NCT06660394 Phase 3
Recruiting

A Phase 3, Placebo-Controlled Study to Investigate LP352 in Children and Adults With Dravet Syndrome (DS)

Dravet Syndrome
United States, Australia, Belgium View Trial →